Tag: immunochemotherapy

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma

byNeel Mistryand1 others

June 29, 2022

1. Median event-free survival in the liso-cel group was significantly greater than in the standard-of-care group (10.1 months vs. 2.3 ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

The quadrivalent human papillomavirus vaccine provides effective and durable protection against invasive cervical cancer
FDA grants priority review for iberdomide-based myeloma regimen
Placebo may be inferior compared to acetaminophen when given with morphine for the management of acute pain in the emergency department

No Result

View All Result